BioNxt Solutions Inc. (CVE:BNXT) | Finanzwire

Basculer en Français

9473	Companies
185396	Keywords
117753	Articles
99279	Press releases

Headlines Articles Press releases BioNxt Solutions Inc.

Home
Companies
BioNxt Solutions Inc.

BRIEF

published on 06/23/2025 at 09:10, 5 months 11 days ago

BioNxt Explores New Delivery Method for Semaglutide with Feasibility Study

Feasibility Study Drug Delivery BioNxt Solutions Semaglutide GLP-1 Therapy
PRESS RELEASE

published on 06/23/2025 at 09:05, 5 months 11 days ago

BioNxt Launches Feasibility Study for Semaglutide Oral Thin Film as Alternative to Injection/Tablets
BioNxt Solutions Inc. launches feasibility study for oral dissolvable film of Semaglutide, a GLP-1 receptor agonist, to improve patient experience and adherence. Study aims to assess compatibility and generate data for formulation optimization and patent strategy

BioNxt Solutions Inc. Feasibility Study GLP-1 Receptor Agonist Oral Dissolvable Film Semaglutide
BRIEF

published on 06/13/2025 at 01:05, 5 months 22 days ago

BioNxt Solutions Updates on Management Cease Trade Order Status

Financial Statements Regulatory Compliance Audit Completion MCTO Update BioNxt Solutions
PRESS RELEASE

published on 06/13/2025 at 01:00, 5 months 22 days ago

BioNxt Solutions Provides Bi-Weekly MCTO Status Report
BioNxt Solutions provides an update on the management cease trade order from BCSC, ensuring efforts to file required financial documents by June 30, 2025

Management Cease Trade Order BCSC Filing Deadline Financial Documents BioNxt Solutions
BRIEF

published on 05/30/2025 at 01:05, 6 months 6 days ago

BioNxt Solutions Updates on Management Cease Trade Order Status

MCTO Financial Filing BCSC BioNxt Solutions Audit Progress
PRESS RELEASE

published on 05/30/2025 at 01:00, 6 months 6 days ago

BioNxt Solutions Provides Bi-weekly MCTO Status Report
BioNxt Solutions Inc. announces management cease trade order by BCSC until required financial statements are filed. Company's progress on compliance and commitment to regulation outlined

Financial Statements Regulatory Compliance Management Cease Trade Order BCSC BioNxt Solutions Inc.
BRIEF

published on 05/23/2025 at 09:10, 6 months 12 days ago

BioNxt Solutions Set to Receive European Patent for Drug Delivery System

Drug Development Multiple Sclerosis European Patent BioNxt Solutions Sublingual Delivery
PRESS RELEASE

published on 05/23/2025 at 09:05, 6 months 12 days ago

BioNxt Solutions Reports Formal Notice from the European Patent Office of Intention to Grant Patent
BioNxt Solutions Inc. announces European Patent Office's intention to grant their core patent for advanced drug delivery systems, focusing on sublingual anticancer treatments

BioNxt Solutions Inc. European Patent Office Drug Delivery Systems Sublingual Anticancer Treatments
BRIEF

published on 05/16/2025 at 01:35, 6 months 20 days ago

BioNxt Solutions Provides MCTO Status Update

Financial Statements Regulatory Compliance Shareholder Information MCTO Audit Process
PRESS RELEASE

published on 05/16/2025 at 01:30, 6 months 20 days ago

Bionxt Solutions Provides Bi-Weekly MCTO Status Report
BioNxt Solutions Inc. announces a management cease trade order granted by the BC Securities Commission affecting the CEO and CFO from trading until Required Documents filed by June 30, 2025

Management Cease Trade Order BioNxt Solutions Inc. Filing Deadline BC Securities Commission Required Documents

Accesswire

Published on 12/05/2025 at 02:35, 6 hours 10 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 6 hours 15 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 7 hours 45 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 40 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 45 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 08:30, 15 minutes ago

Dahua Technology Celebrates Pro Challenge 2025 to Deepen Global Installer Ecosystem Collaboration
Published on 12/05/2025 at 08:30, 15 minutes ago

Premier Miton Global Renewables Trust PLC - Suspension
Published on 12/05/2025 at 08:05, 40 minutes ago

Smartmi Unveils the Air Purifier 3: Powerful, Smart, and Stylish Air Care for Modern Homes
Published on 12/05/2025 at 08:01, 44 minutes ago

Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):
Published on 12/05/2025 at 08:01, 44 minutes ago

Custodian Property Income REIT plc: Interim results for the period ended 30 September 2025

Les Echos

Published on 12/04/2025 at 18:00, 14 hours 45 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 15 hours ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 15 hours 1 minute ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 1 hour ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 14 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE